澳大利亚封锁672M美元美国接管Mayne Pharma公司, Australia blocks $672M U.S. takeover of Mayne Pharma over national interest concerns.

澳大利亚政府阻止了6.72亿美元的美国对Mayne Pharma的接管, 并列举了对关键药品供应、200个工作岗位和主权研究能力所受威胁的国家利益关切。 The Australian government has blocked a $672 million U.S. takeover of Mayne Pharma, citing national interest concerns over threats to critical medicine supply, 200 jobs, and sovereign research capabilities. 财政部长吉姆·查尔默斯支持外国投资审查委员会及多个联邦和州机构的建议，认为任何条件都无法降低风险，尤其是在美国公司科赛特威胁关闭梅恩位于阿德莱德的工厂之后。 Treasurer Jim Chalmers upheld advice from the Foreign Investment Review Board and multiple federal and state agencies that no conditions could mitigate the risks, particularly after U.S. firm Cosette threatened to close Mayne’s Adelaide factory. 在最高法院试图强迫出售以及Mayne股价暴跌之后,这项裁决结束了几个月的不确定状态。 The decision ends months of uncertainty, following a failed Supreme Court attempt to force the sale and a sharp drop in Mayne’s share price. 交易在宣布前停止,股票下降20%以上,跌至4.60美元。 Trading was halted ahead of the announcement, and shares fell over 20% to $4.60.